Stroke models in vivo can be established by selecting appropriate model animals and suitable model building conditions to better simulate certain specific processes in humans, to help better understand the specific pathogenesis of ischemic and hemorrhagic stroke, and to verify the effectiveness of drug candidates for stroke treatment. There are many variables in the stroke process, which is a great challenge for stroke research and model building. Therefore, the establishment of stable and controlled stroke models is fundamental to stroke research.
In Vivo Modeling of Ischemic Stroke
Ischemic stroke is the most common form of stroke worldwide, with rapid onset and severe damage. There is no effective cure for stroke. Therefore, research into ischemic stroke remains a long way off. There are many studies on ischemic stroke, but there are some differences in some results due to differences in many factors, such as modeling conditions. Therefore, stable and mature ischemic stroke models can effectively avoid such problems. Meanwhile, our model animals are strictly managed by professional scientists to ensure scientific and rigorous research. Our models include intraluminal suture MCAO models, craniectomy models, photothrombosis models, endothelin-1 models, embolic models, and other models.
In Vivo Hemorrhagic Stroke Model
Although hemorrhagic stroke accounts for a small percentage of strokes overall, it is an extremely serious risk to human health. The number of studies on hemorrhagic stroke is far less than that on ischemic stroke, but this does not mean that hemorrhagic stroke research can be stagnant. With our stable and proven technology and professional scientists, we have established various hemorrhagic stroke models to facilitate hemorrhagic stroke research. Our models include autologous blood injection models, bacterial collagenase injection models, balloon inflation models, endovascular filament models, blood injection models, prechiasmatic models, cisterna magna models, and other models.